XML 34 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Series A-1 Redeemable Convertible Preferred Stock
Series A-2 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Beginning Balance at Dec. 31, 2020 $ (59,065) $ 1 $ 2,158   $ (61,224)      
Beginning Balance, Shares at Dec. 31, 2020   505,074            
Beginning Balance at Dec. 31, 2020           $ 2 $ 42,786 $ 64,548
Beginning Balance, Shares at Dec. 31, 2020           20,000,000 107,194,866 124,519,220
Issuance of redeemable convertible preferred stock               $ 45,375
Issuance of redeemable convertible preferred stock, Shares               87,259,605
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering           $ (2) $ (42,786) $ (109,923)
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares           (20,000,000) (107,194,866) (211,778,825)
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering 152,711 $ 2 152,709          
Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares   24,924,501            
Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees of $17,132 186,308 $ 1 186,307          
Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees, Shares   11,302,219            
Issuance of common stock upon vesting and exercise of stock options 894   894          
Issuance of common stock upon vesting and exercise of stock options, Shares   442,947            
Stock-based compensation expense 4,314   4,314          
Net loss (68,899)       (68,899)      
Ending Balance at Dec. 31, 2021 $ 216,263 $ 4 346,382   (130,123)      
Ending Balance, Shares at Dec. 31, 2021 37,174,741 37,174,741            
Issuance of common stock upon vesting and exercise of stock options $ 1,233   1,233          
Issuance of common stock upon vesting and exercise of stock options, Shares   671,796            
Issuance of common stock upon vesting of restricted stock units, Shares   319,155            
Issuance of common stock under the employee stock purchase plan 117   117          
Issuance of common stock under the employee stock purchase plan, Shares   34,242            
Issuance of common stock from at-the-market sales agreements 4,356   4,356          
Issuance of common stock from at-the-market sales agreements, Shares   866,030            
Issuance of common stock from offering and concurrent private placement, net of issuance costs 110,807 $ 3 110,804          
Issuance of common stock from offering and concurrent private placement, net of issuance costs, Shares   26,930,174            
Stock-based compensation expense 10,695   10,695          
Other comprehensive loss, net of tax (770)     $ (770)        
Net loss (92,094)       (92,094)      
Ending Balance at Dec. 31, 2022 $ 250,607 $ 7 $ 473,587 $ (770) $ (222,217)      
Ending Balance, Shares at Dec. 31, 2022 65,996,138 65,996,138